FindMyRecallSubscribe
Class I: serious health riskTerminated

Mylan Institutional Tranexamic Acid Injection Recall

Tranexamic Acid Injection, USP, 1000 mg/10 mL (100 mg/mL), 10 mL Single-Dose Vial (NDC…

Mylan Institutional LLC · Rockford, IL

Risk level
Class I
Reported by FDA
Sep 9, 2020
Recall ID
D-1576-2020
Check your lot numberHow we source this data

Summary

Mylan Institutional recalled Tranexamic Acid Injection starting Aug 17, 2020. The FDA classified it as Class I (serious health risk) and published enforcement report D-1576-2020 on Sep 9, 2020. Reason: Labeling: Label Mix-Up; potential for cartons labeled as Tranexamic Acid Injection, USP to contain vials of Amiodarone HCl Injection, USP and cartons labeled as Amiodarone HCl Injection, USP to contain vials of Tranexamic Acid Injection, USP. Status: Terminated.

Why it was recalled

Labeling: Label Mix-Up; potential for cartons labeled as Tranexamic Acid Injection, USP to contain vials of Amiodarone HCl Injection, USP and cartons labeled as Amiodarone HCl Injection, USP to contain vials of Tranexamic Acid Injection, USP.

Product description

Tranexamic Acid Injection, USP, 1000 mg/10 mL (100 mg/mL), 10 mL Single-Dose Vial (NDC 67457-197-00); 10 x 10 mL Single-Dose Vials per carton (NDC 67457-197-10), Rx only, Manufactured by: Mylan Institutional, Galway, Ireland; Manufactured for: Mylan Institutional LLC, Rockford, IL 61103.

Lot numbers, UPCs & expiration codes

Lot #: 191207, 191221, 191223, Exp. 11/2021; 200120 Exp. 12/2021

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1576-2020
Classification
Class I
Status
Terminated
Recall initiated
Aug 17, 2020
FDA report date
Sep 9, 2020
Quantity
1407 cartons
Recall type
Voluntary: Firm initiated
Recalling firm
Mylan Institutional LLC

Original FDA data

Every field from FDA enforcement report D-1576-2020, exactly as published.

Show all FDA fields
City
Rockford
State
IL
Status
Terminated
Country
United States
Event ID
86247
Address
4901 Hiawatha Dr
Code information
Lot #: 191207, 191221, 191223, Exp. 11/2021; 200120 Exp. 12/2021
Postal code
61103-1287
Report date
Sep 9, 2020
Product type
Drugs
Recall number
D-1576-2020
Classification
Class I
Recalling firm
Mylan Institutional LLC
Product quantity
1407 cartons
Termination date
Dec 28, 2022
Reason for recall
Labeling: Label Mix-Up; potential for cartons labeled as Tranexamic Acid Injection, USP to contain vials of Amiodarone HCl Injection, USP and cartons labeled as Amiodarone HCl Injection, USP to contain vials of Tranexamic Acid Injection, USP.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Tranexamic Acid Injection, USP, 1000 mg/10 mL (100 mg/mL), 10 mL Single-Dose Vial (NDC 67457-197-00); 10 x 10 mL Single-Dose Vials per carton (NDC 67457-197-10), Rx only, Manufactured by: Mylan Institutional, Galway, Ireland; Manufactured for: Mylan Institutional LLC, Rockford, IL 61103.
Distribution pattern
Nationwide
Recall initiation date
Aug 17, 2020
Initial firm notification
Letter
Center classification date
Sep 11, 2020

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1576-2020, published Sep 9, 2020. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls